The LDN Book 3 - US Orders - FREE Shipping

The LDN Book, Volume 3 is both a resource for practitioners, pharmacists and patients and a renewed call for further research on the healing potential of this generic drug. Click to see a Sample Contributing Authors: Preface Linda Elsegood, Founder LDN Research Trust. Foreword by Pamela W. Smith, M.D., MPD, MS. Pharmacology and Best Clinical Practices by J. Stephen Dickinson, BSC (hons) MRPharmS. Drug-Resistant Depression by Dr. Elizabeth Livengood, NMD Virally Damaged Tissues (including: COVID-19, Herpes Simplex (HSV 1 & 2),Varicella-Zoster, Human Parvovirus B19 (B19V) & Epstein-Barr (EBV) by Sarah J. Zielsdorf, MD, MS. LDN and Longevity by Yusuf M. (JP) Saleeby, MD.  Mixed Connective Tissue Disease by Deanna Windham, DO. Mold Illness and CIRS by Kent Holtorf, MD.  Ophthalmic Conditions by Sebastian Denison, RPh, FAAR. Long COVID by Professor Angus G. Dalgleish, FRCP FRCPath FMedSci and Wai M. Liu, PhD. Cancer and Case Studies by Angus Dalgleish,FRCP FRCPath FMedSc Wai M. L